ICOSLG Immune Checkpoint

 

The immune checkpoint ICOSLG is a ligand for the T-cell-specific cell surface receptor ICOS. ICOSLG acts as a co-stimulatory signal for T-cell proliferation and cytokine secretion; induces also B-cell proliferation and differentiation into plasma cells.


Risk-Free™ ICOSLG Antibody Development Progress

ProSci's Risk-Free™ antibodies are monoclonal antibodies made to improve in vitro studies. Unlike antibodies developed using proteins made in yeast or bacteria, Risk-Free™ antibodies are developed with antigens expressed in mammalian cell lines, giving the most native post-translational modifications to the protein. Risk-Free™ means they are guaranteed to work for their approved applications.

Risk-Free™ Mouse Monoclonal ICOSLG Antibodies

  • ImmunizationPhase Duration:
    About 2 to 3 months
  • FusionPhase Duration:
    About 1 to 2 months
  • CloningPhase Duration:
    About 2 to 3 months
  • ValidationPhase Duration:
    About 1 month
  • Release

Have Questions About Our ICOSLG Antibody?

I am NOT interested in receiving promotions, discounts or news.